Value elements and methods of value-based pricing for drugs in Japan: a systematic review-Reference-Cited by-同舟云学术

Value elements and methods of value-based pricing for drugs in Japan: a systematic review

Published:2023-06-20 Issue:7 Volume:23 Page:749-759
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Takami Akina¹²,Kato Masafumi¹,Deguchi Hisato¹^ORCID,Igarashi Ataru²³^ORCID

Affiliation:

1. Market Access, Public Affairs & Patient Experience, Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan

2. Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan

3. Department of Public Health, School of Medicine, Yokohama City University, Yokohama, Japan

Funder

Takeda Pharmaceuticals

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2223984

Reference78 articles.

1. Value-Based Health Care Meets Cost-Effectiveness Analysis

2. Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3]

3. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

4. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines) with NCCN Evidence Blocks™. Available from: https://www.nccn.org/guidelines/guidelines-with-evidence-blocks. Accessed Nov 28, 2022.

5. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Expert Review of Pharmacoeconomics & Outcomes Research;2023-12-21

2. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Journal of Medical Economics;2023-12-20

3. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Current Medical Research and Opinion;2023-12-20

4. What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends;ClinicoEconomics and Outcomes Research;2023-12